# 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/3d-qsar-and-docking-studies-on-4-anilinoquinazoline-and-4-anilinoquinoline/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haregewein Assefa,Shantaram Kamath,John K. Buolamwini |
| Citations | 60 |
| DOI | 10.1023/b:jcam.0000004622.13865.4f |
| Fields | Biochemistry, Genetics and Molecular Biology,Computer Science,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1988345806 |
| PMID | 14703120 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Haregewein Assefa](https://scholariq.org/researchers/haregewein-assefa/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.